category,datetime,headline,id,image,related,source,summary,url
company,1769523900,Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business,138271174,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,WAT,Yahoo,"Waters Corporation (NYSE: WAT) (the ""Company"" or ""Waters"") today announced that, at the Company's Special Meeting of Shareholders (the ""Special Meeting"") held today, Waters shareholders overwhelmingly voted to approve the issuance of shares of Waters common stock to shareholders of Becton, Dickinson and Company (NYSE: BDX) (""BD"") in connection with the proposed combination of BD's Biosciences & Diagnostic Solutions business with Waters.",https://finnhub.io/api/news?id=9eb4e108807a4d4dca469d3434de469be4aded2420b0caede44d157671dd378a
company,1769523900,BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business,138271173,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,WAT,Yahoo,"BD (Becton, Dickinson and Company) (NYSE: BDX) (""BD"" or the ""Company"") today announced that the Company's Board of Directors has set the close of business on February 5, 2026, as the record date for the previously announced spin-off of BD's Biosciences & Diagnostic Solutions business to BD's shareholders. Immediately following the spin-off, the spun-off entity will be combined with Waters Corporation (NYSE: WAT) (""Waters"") in a Reverse Morris Trust transaction. The combination is expected to be",https://finnhub.io/api/news?id=c323e61642a9d1b2f139c8e656b319ea6e49fd20ba923f344496ce106ad7e47d
